M Ventures — 2016 Investments
1 investments dated 2016 · listed companies and verified rows first · show all
Artios Pharmaartios.comin𝕏Series A · Sep 2016 · $33M
Artios develops DNA damage response (DDR)-based medicines targeting patients with high unmet need cancers.
BiotechHealthtechMedical Devices
Co-investorsAndera PartnersDementia Discovery FundNovartis Venture FundPfizer Venture InvestmentsRA CapitalSofinnova Partners+6 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.



